Immunovant Inc

NASDAQ:IMVT   4:00:00 PM EDT
16.42
-0.53 (-3.13%)
5:07:13 PM EDT: $16.41 -0.01 (-0.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immunovant Inc Stock, NASDAQ:IMVT

320 West 37th Street, 6th floor, New York, New York 10018
United States of America
Phone: +1.917.580.3099
Number of Employees: 207
http://www.immunovant.com

Description

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.